I have opined in the past that there are only a select few "value driven" money managers that I respect for their skill and have a good track record over complete market cycles. One such fund is the Jensen Fund (JENSX). Click on the above blog title to read an article from www.theStreet.com.
NEW YORK (TheStreet) -- Health-care stocks barely budged last year as worry over legislation kept them from joining the broader equity-market rally. Robert Zagunis, manager of the Jensen Fund, says this year will be different, especially for companies such as:
- Medtronic(MDT)
- Abbott Labs(ABT)
- Stryker(SYK).
I agree with Robert's conclusion. Medtronic was purchased in 2010 in our portfolios, with Abbott and Stryker added the first week of January 2011. All three of the above mentioned stocks qualify as WFG Paid to Wait stocks and are owned in our privately managed accounts and our no load mutual fund.
